Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matthias Heldwein

Showing results (11-20 of 24) with videos related to

Pageof 3
Sort By:
Thorax|March 11, 2019
Transbronchial cryobiopsy in fibrosing interstitial lung disease: modifications of the procedure lead to risk reductionLars Hagmeyer, Dirk Theegarten, Jeremias Wohlschläger, et al.
Surgical Oncology|June 23, 2022
Hemangiosis carcinomatosa as an independent risk factor for long-term survival in Non-Small Cell Lung Cancer patientsMatthias Heldwein, Hruy Menghesha, Fabian Doerr, et al.
Lung Cancer (Amsterdam, Netherlands)|June 4, 2025
Development and clinical validation of a prognostic algorithm for stroma-tumor ratio quantification in non-small cell lung cancerWaleed K M Ahmad, Tillmann Bedau, Yuan Wang, et al.
Neurological Research and Practice|June 14, 2023
The impact of thymectomy in subgroups of Myasthenia gravis patients: a single center longitudinal observationHruy Menghesha, Michael Schroeter, Christopher Nelke, et al.
Journal of Personalized Medicine|February 25, 2025
Is CK7 a Prognostic Marker in Pulmonary LCNEC? Evidence from a Limited Cohort StudyHruy Menghesha, Donatas Zalepugas, Amina Camo, et al.
ERJ Open Research|March 29, 2021
High sensitivity of PD-L1 analysis from pleural effusion in nonsmall cell lung cancerLars Hagmeyer, Stephan Schäfer, Marianne Engels, et al.
Medcomm|September 10, 2025
AI Algorithm for Lung Adenocarcinoma Pattern Quantification (PATQUANT): International Validation and Advanced Risk Stratification Superior to Conventional GradingYuan Wang, Kris Lami, Waleed Ahmad, et al.
Lung Cancer (Amsterdam, Netherlands)|December 1, 2020
Detection of circulating tumor DNA by digital droplet PCR in resectable lung cancer as a predictive tool for recurrenceAsmae Gassa, Jana Fassunke, Sarah Schueten, et al.
European Journal of Cancer (Oxford, England : 1990)|December 15, 2023
TTF-1 status in early-stage lung adenocarcinoma is an independent predictor of relapse and survival superior to tumor gradingSimon Schallenberg, Gabriel Dernbach, Mihnea P Dragomir, et al.
Cancers|February 24, 2024
LIONS PREY: A New Logistic Scoring System for the Prediction of Malignant Pulmonary NodulesFabian Doerr, Annika Giese, Katja Höpker, et al.
Pageof 3

Showing results (11-20 of 24) with videos related to

Sort By:
Pageof 3
Thorax|March 11, 2019
Transbronchial cryobiopsy in fibrosing interstitial lung disease: modifications of the procedure lead to risk reductionLars Hagmeyer, Dirk Theegarten, Jeremias Wohlschläger, et al.
Surgical Oncology|June 23, 2022
Hemangiosis carcinomatosa as an independent risk factor for long-term survival in Non-Small Cell Lung Cancer patientsMatthias Heldwein, Hruy Menghesha, Fabian Doerr, et al.
Lung Cancer (Amsterdam, Netherlands)|June 4, 2025
Development and clinical validation of a prognostic algorithm for stroma-tumor ratio quantification in non-small cell lung cancerWaleed K M Ahmad, Tillmann Bedau, Yuan Wang, et al.
Neurological Research and Practice|June 14, 2023
The impact of thymectomy in subgroups of Myasthenia gravis patients: a single center longitudinal observationHruy Menghesha, Michael Schroeter, Christopher Nelke, et al.
Journal of Personalized Medicine|February 25, 2025
Is CK7 a Prognostic Marker in Pulmonary LCNEC? Evidence from a Limited Cohort StudyHruy Menghesha, Donatas Zalepugas, Amina Camo, et al.
ERJ Open Research|March 29, 2021
High sensitivity of PD-L1 analysis from pleural effusion in nonsmall cell lung cancerLars Hagmeyer, Stephan Schäfer, Marianne Engels, et al.
Medcomm|September 10, 2025
AI Algorithm for Lung Adenocarcinoma Pattern Quantification (PATQUANT): International Validation and Advanced Risk Stratification Superior to Conventional GradingYuan Wang, Kris Lami, Waleed Ahmad, et al.
Lung Cancer (Amsterdam, Netherlands)|December 1, 2020
Detection of circulating tumor DNA by digital droplet PCR in resectable lung cancer as a predictive tool for recurrenceAsmae Gassa, Jana Fassunke, Sarah Schueten, et al.
European Journal of Cancer (Oxford, England : 1990)|December 15, 2023
TTF-1 status in early-stage lung adenocarcinoma is an independent predictor of relapse and survival superior to tumor gradingSimon Schallenberg, Gabriel Dernbach, Mihnea P Dragomir, et al.
Cancers|February 24, 2024
LIONS PREY: A New Logistic Scoring System for the Prediction of Malignant Pulmonary NodulesFabian Doerr, Annika Giese, Katja Höpker, et al.
Pageof 3